GlaxoSmithKline Is Mouthful But Still Hungry: Is Next Course Japanese?

GlaxoSmithKline's acquisition strategy will concentrate on medium-sized pharmaceutical and biotech companies with a pipeline, CEO J.P. Garnier told analysts during a Feb. 22 meeting in London.